Creativity enhancement
Creativity enhancement is defined as an increase in one's capability to imagine new ideas, create art, or think about existing concepts in a novel manner.[1] This effect is particularly useful to artists of any sort because it can help a person overcome creative blocks on existing projects and induce inspiration for entirely new projects. Creativity enhancement can make imaginative activities more enjoyable and effortless in the moment and the inspiration from it can benefit the individual even after the effect has worn off.
A well-known example of psychedelic creativity enhancement comes from the Nobel Prize winning chemist Dr. Kary Mullis, who invented a method for copying DNA segments known as the PCR and is quoted as saying: "Would I have invented PCR if I hadn't taken LSD? I seriously doubt it. I could sit on a DNA molecule and watch the polymers go by. I learned that partly on psychedelic drugs".[2] In addition, although dubious, it has been claimed Francis Crick experimented with LSD during the time he helped elucidate the structure of DNA.[3] Many artists (such as The Beatles) have also attributed creativity enhancing properties to psychedelics like LSD.[citation needed]
Creativity enhancement is often accompanied by other coinciding effects such as thought connectivity, motivation enhancement, personal bias suppression, analysis enhancement, and thought acceleration in a manner which further amplifies a person's creativity. It is most commonly induced under the influence of moderate dosages of psychedelic compounds, such as LSD, psilocybin, and mescaline.[4][5][6] However, it can also occur to a lesser extent under the influence of cannabinoids,[7][8] dissociatives,[9] and stimulants.
Psychoactive substances
Compounds within our psychoactive substance index which may cause this effect include:
- 1B-LSD
- 1P-LSD
- 1V-LSD
- 1cP-LSD
- 2-Fluorodeschloroketamine
- 25E-NBOH
- 2C-B
- 2C-B-FLY
- 2C-E
- 2C-EF
- 2C-P
- 3-Cl-PCP
- 3-MeO-PCE
- 3-MeO-PCMo
- 3-MeO-PCP
- 4-AcO-DMT
- 4-HO-MET
- 4-HO-MiPT
- 4-MeO-PCP
- 6-APB
- 6-APDB
- ALD-52
- Aniracetam
- Ayahuasca
- Bromo-DragonFLY
- Cannabis
- DMT
- Deschloroketamine
- Dextromethorphan
- Ephenidine
- GBL
- GHB
- HXE
- LSD
- LSZ
- Lisdexamfetamine
- MDA
- MDEA
- MDMA
- MDPV
- MET
- MXiPr
- Memantine
- Mescaline
- Methoxetamine
- MiPT
- O-PCE
- PCE
- PCP
- Pregabalin
Experience reports
Annectdotal reports which describe this effect with our experience index include:
- Experience: 32mg 2C-B - Bromo Mescaline
- Experience:1.2 g gabapentin, alcohol, and half of 150 mg Effexor XR - Pretty lovely for socializing and giggles
- Experience:100ug 1P-LSD - A Fear and loathing into Bliss
- Experience:25mg 3-MeO-PCP - Enhanced film experience
- Experience:3 Grams of Mushrooms - Reset on my Life, Experiencing Satori and the Cosmic Perspective
- Experience:4F-EPH (15mg) - Untitled
- Experience:BK-2C-B - Various experiences
- Experience:LSD (230 ug) - An amazing adventure by vikilikepsych
See also
- Responsible use
- Subjective effects index
- Creativity suppression
- Psychedelics - Subjective effects
- Stimulants - Subjective effects
External links
References
- ↑ Iszáj, Fruzsina; Griffiths, Mark D.; Demetrovics, Zsolt (2016). "Creativity and Psychoactive Substance Use: A Systematic Review". International Journal of Mental Health and Addiction. 15 (5): 1135–1149. doi:10.1007/s11469-016-9709-8. ISSN 1557-1874.
- ↑ Hongbao, M. (2005). "Development Application Polymerase Chain Reaction (PCR)" (PDF). The Journal of American Science. 1 (3): 1–15.
- ↑ Brooks, M. (2012). Free radicals: the secret anarchy of science (1st U.S. hardcover ed ed.). Overlook Press. ISBN 9781590208540.
- ↑ Sessa, B. (2008). "Is it time to revisit the role of psychedelic drugs in enhancing human creativity?". Journal of Psychopharmacology. 22 (8): 821–827. doi:10.1177/0269881108091597. ISSN 0269-8811.
- ↑ Krippiwr, Stanley (2008). "Research in creativity and psychedelic drugs". International Journal of Clinical and Experimental Hypnosis. 25 (4): 274–290. doi:10.1080/00207147708415985. ISSN 0020-7144.
- ↑ Krippner, Stanley (1985). "Psychedelic Drugs and Creativity". Journal of Psychoactive Drugs. 17 (4): 235–246. doi:10.1080/02791072.1985.10524328. ISSN 0279-1072.
- ↑ Green, Bob; Kavanagh, David; Young, Ross (2003). "Being stoned: a review of self-reported cannabis effects". Drug and Alcohol Review. 22 (4): 453–460. doi:10.1080/09595230310001613976. ISSN 0959-5236.
- ↑ Kowal, Mikael A.; Hazekamp, Arno; Colzato, Lorenza S.; van Steenbergen, Henk; van der Wee, Nic J. A.; Durieux, Jeffrey; Manai, Meriem; Hommel, Bernhard (2014). "Cannabis and creativity: highly potent cannabis impairs divergent thinking in regular cannabis users". Psychopharmacology. 232 (6): 1123–1134. doi:10.1007/s00213-014-3749-1. ISSN 0033-3158.
- ↑ Muetzelfeldt, L., Kamboj, S. K., Rees, H., Taylor, J., Morgan, C. J. A., Curran, H. V. (June 2008). "Journey through the K-hole: Phenomenological aspects of ketamine use". Drug and Alcohol Dependence. 95 (3): 219–229. doi:10.1016/j.drugalcdep.2008.01.024. ISSN 0376-8716.